Polymerase Chain Reaction (PCR) Technologies Market Competitive And Growth Analysis 2024 | F. Hoffmann-La Roche Ltd., Bayer Corporation, Thermo Fisher Scientific Inc

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Polymerase Chain Reaction (PCR) Technologies Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $23.02 billion In 2028 At A CAGR Of 12.1% :

The PCR technologies market size has grown rapidly in recent years. It will grow from $13.03 billion in 2023 to $14.58 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to the increased number of genome-based drug development activities, growth in the prevalence of genetic disorders and target diseases, increased use of miniaturized portable instruments, growth in use of biomarker profiling, and growth in demand for personalized medicine.

The PCR technologies market size is expected to see rapid growth in the next few years. It will grow to $23.02 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to a rise in demand for rapid and accurate diagnosis of disease, growing demand for forensics, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include next-generation sequencing (NGS) integration, RNA detection and analysis, single-cell PCR analysis, bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), artificial intelligence (AI) and data analytics.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15639&type=smp

Polymerase Chain Reaction (PCR) Technologies Market Major Segments
The polymerase chain reaction (PCR) technologies market covered in this report is segmented -

1) By Product: Reagents And Consumables, Instruments, Software, Services
2) By Technology: Real-Time Polymerase Chain Reaction, Conventional Polymerase Chain Reaction, Reverse Transcription Polymerase Chain Reaction, Digital Polymerase Chain Reaction, Multiplex Real-Time (RT) Polymerase Chain Reaction, Hot Start Polymerase Chain Reaction, Other Technologies
3) By Application: Gene Expression Analysis, Genetic Sequencing, Genotyping, Nucleic Acid Synthesis, Standard Validation, Point Of Care Diagnostics, Environmental Application, Other Applications
4) By End Users: Hospitals And Diagnostic Centers, Research Laboratories And Academic Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Key Driver - Rising Cigarette Smoking Boost The Adrenal Cancer

An increasing prevalence of infectious diseases is expected to propel the growth of the PCR technologies market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The increasing prevalence of infectious diseases highlights the growing challenges posed by pathogens, potentially due to factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. PCR technologies mitigate the prevalence of infectious diseases by detecting and amplifying specific genetic material of pathogens, aiding in their identification and diagnosis with high sensitivity and accuracy. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, 10.6 million cases of tuberculosis (TB) are predicted to occur globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the PCR technologies market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15639&type=smp

Prominent Trend - Technological Advancements In Polymerase Chain Reaction (PCR) Technologies

Major companies operating in the PCR technologies market are focused on developing advanced technological solutions, such as next-gen quantitative polymerase chain reaction (qPCR) technologies, to improve accuracy, sensitivity, and efficiency in molecular diagnostics. Quantitative polymerase chain reaction (qPCR) technology quantifies specific DNA sequences in samples, offering real-time monitoring and amplification, rendering it invaluable across scientific and medical disciplines. For instance, in November 2023, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology company, launched the LightCycler PRO System, a next-generation qPCR (quantitative polymerase chain reaction) system designed to advance clinical needs in molecular diagnostics and address public health challenges. This system is intended to be the most advanced qPCR technology for both clinical diagnostics and research, offering improved performance and usability while bridging the gap between translational research and in vitro diagnostics. It harness gold-standard technology, ensuring quality, precision, and reliability essential for precise patient diagnosis and informed clinical decisions.

Polymerase Chain Reaction (PCR) Technologies Market Players
Major companies operating in the polymerase chain reaction (PCR) technologies market are F. Hoffmann-La Roche Ltd., Bayer Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company (BD), GE Healthcare Technologies LLC , Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ambry Genetics Corporation, Veritas Genetics Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-technologies-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the PCR technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Polymerase Chain Reaction (PCR) Technologies Market Report Structure
3. Polymerase Chain Reaction (PCR) Technologies Market Trends And Strategies
4. Polymerase Chain Reaction (PCR) Technologies Market - Macro Economic Scenario
5. Polymerase Chain Reaction (PCR) Technologies Market Size And Growth
…..
27. Polymerase Chain Reaction (PCR) Technologies Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.